Circle Pharma
Latest round
- Series D
Last raised
- Jun 2024
Total raised
- $111M
Investors
- 13
About Circle Pharma
Circle Pharma, Inc. specializes in developing innovative macrocycle therapeutics aimed at treating various advanced solid tumors., established in 2012 and headquartered in San Francisco, US, focuses on creating cell-permeable macrocycle therapeutics.Circle Pharma, Inc. specializes in the development of cell-permeable macrocycle therapeutics, focusing on its proprietary MXMO™ platform. Its leading product, CID-078, is a first-in-class oral macrocycle cyclin A/B RxL inhibitor undergoing Phase 1 clinical trials for advanced solid tumors, including small cell lung cancer, triple-negative breast cancer, and estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast cancer.Circle Pharma's revenue model revolves around partnerships and clinical trials as it advances its investigational therapies. Collaborations with research institutions and pharmaceutical partners support the development and commercialization of its macrocycle therapeutics. Revenue may arise from milestone payments associated with clinical trial advancements, regulatory approvals, and product launches. Additionally, licensing agreements may yield upfront payments and royalties based on product sales.Circle Pharma, Inc. The company aims to advance CID-078 through clinical trials and is exploring the potential introduction of additional products based on its MXMO™ platform. Future expansion is targeted towards new geographic markets, particularly within the US, where there is an urgent need for effective cancer therapeutics. As the company progresses with its pipeline, it is focused on meeting critical demands in oncology care.
Who invested in Circle Pharma
13 investors across 6 rounds
See all investors in Circle Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Circle Pharma
Who invested in Circle Pharma?
Circle Pharma has 13 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Circle Pharma raised?
Circle Pharma has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Circle Pharma last raise money?
Circle Pharma's most recent round on record is a Series D, in Jun 2024.
What does Circle Pharma do?
Circle Pharma is a pharmaceuticals company.
Where is Circle Pharma headquartered?
Circle Pharma is headquartered in San Francisco, US.
Which VCs invest in companies like Circle Pharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Circle Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Circle Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.